Interview: Biocon MD, Kiran Mazumdar Shaw

Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook

Kiran Mazumdar Shaw of Biocon on business outlook

Don't think the budget has moved the needle in improving consumption, says Kiran Mazumdar Shaw of Biocon

Allow companies to provide booster doses to employees: Biocon chief Kiran Mazumdar-Shaw | EXCLUSIVE

Biocon chief Kiran Mazumdar Shaw questions govt's Covid vaccine policy

Covid-19 | A message from Biocon chief Kiran Mazumdar Shaw

ಕರ್ನಾಟಕದ ಬಯೋಕಾನ್​ನಲ್ಲಿ ಸಿದ್ದವಾಗ್ತಿದೆ ವ್ಯಾಕ್ಸಿನ್​ | Biocon | Kiran Mazumdar Shaw | TV5 Kannada

Catch Kiran Mazumdar Shaw - CMD of Biocon in an exclusive conversation with ET NOW as she speaks about Rajan returning to academia.

Kiran Mazumdar of Biocon on launch of insulin glargine

kiran-mazumdar-shaw-at-global-technology-summit

Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections

Kiran Mazumdar Shaw On Fighting and Recovering From COVID-19: ‘Dont Panic, Be Positive

Interview: Biocon's Chairman MD: Kiran Mazumdar-Shaw

Safe place to be in if coronavirus mortality rate brought down: Kiran Mazumdar Shaw

Kiran Mazumdar-Shaw on why India needs to open up after May 3rd 

Kiran Mazumdar-Shaw | Compassionate capitalism

Kiran Mazumdar-Shaw | Entrepreneurship made me aware of social needs

Kiran Mazumdar-Shaw | Certain investments should be considered philanthropic

Look forward to an IPO in next 18-24 months, says Biocon’s Kiran Mazumdar Shaw

Jakson Group Bets On Solar & Sustainability | NDTV Profit

What Women Need To Know About Inheritance | Big Decisions Episode 3 With Bijal Ajinkya

Small & Midcap Outperformance To Reverse? | NDTV Profit

Laurus Labs Q4 Results: CEO Satyanarayana Chava Dissects Numbers | Talking Point | NDTV Profit

What Went Wrong At Kotak Mahindra Bank? | NDTV Profit

Mphasis Q4: Steady Revenue and Profit Growth; Margins Remain Flat | NDTV Profit